Last reviewed · How we verify

NCT05368870

Accuracy of Intra Ocular Lens CARLEVALE Calculation

Completed Last updated 19 January 2024
What this trial tests

trial testing Carlevale implantation in Lens Diseases in 40 participants. Completed in 1 June 2022.

Timeline
1 April 2019
Primary endpoint
1 May 2022
1 June 2022

Quick facts

Lead sponsorPoitiers University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 April 2019
Primary completion1 May 2022
Estimated completion1 June 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Poitiers University Hospital

Who can join

Eligibility, any sex, with Lens Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the accuracy of intra ocular lens power calculation using the new Carlevale sutureless scleral fixation posterior chamber intra ocular lens.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lens Diseases

Currently open trials in the same condition.

Other Poitiers University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05368870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing